Drug
Protandim
Protandim is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
50%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (50.0%)
N/A2 (50.0%)
Trials by Status
completed375%
withdrawn125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments
NCT06429059
withdrawnnot_applicable
Protandim and the Metabolic Syndrome
NCT01125501
completedphase_2
Antioxidant Replacement Therapy in Patients With Alcohol Abuse
NCT00936000
completednot_applicable
The Effect of Protandim on Non-alcoholic Steatohepatitis
NCT00977730
Clinical Trials (4)
Showing 4 of 4 trials
NCT06429059Phase 2
ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments
NCT01125501Not Applicable
Protandim and the Metabolic Syndrome
NCT00936000Phase 2
Antioxidant Replacement Therapy in Patients With Alcohol Abuse
NCT00977730Not Applicable
The Effect of Protandim on Non-alcoholic Steatohepatitis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4